Carregant...

6β-N-Heterocyclic Substituted Naltrexamine Derivative NAP as a Potential Lead to Develop Peripheral Mu Opioid Receptor Selective Antagonists

A 6β-N-heterocyclic substituted naltrexamine derivative, NAP, was proposed as a peripheral mu opioid receptor (MOR) selective antagonist based on the in vitro and in vivo pharmacological and pharmacokinetic studies. To further validate this notion, several functional assays were carried out to fully...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yuan, Yunyun, Stevens, David L., Braithwaite, Amanda, Scoggins, Krista L., Bilsky, Edward J., Akbarali, Hamid I., Dewey, William L., Zhang, Yan
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3395321/
https://ncbi.nlm.nih.gov/pubmed/22683223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2012.05.075
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!